Innovations in Nuclear Medicine Imaging for Reactive Oxygen Species: Applications and Radiopharmaceuticals

被引:0
|
作者
Park, Joo Yeon [1 ]
Park, Sun Mi [1 ]
Lee, Tae Sup [2 ]
Lee, Sang Ju [3 ]
Kim, Ji-Young [4 ]
Oh, Seung Jun [3 ]
Yoon, Hai-Jeon [4 ]
Kim, Bom Sahn [1 ]
Moon, Byung Seok [1 ]
机构
[1] Ewha Womans Univ, Seoul Hosp, Coll Med, Dept Nucl Med, Seoul 07804, South Korea
[2] Korea Inst Radiol & Med Sci, Div RI Applicat, Seoul 01812, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul 05505, South Korea
[4] Ewha Womans Univ, Mokdong Hosp, Coll Med, Dept Nucl Med, Seoul 07985, South Korea
基金
新加坡国家研究基金会;
关键词
reactive oxygen species; nuclear medicine; radiopharmaceutical; positron emission tomography; single photon emission computed tomography; oxidative stress; INDUCED CARDIOTOXICITY; ACID; RADIOTRACER; SUPEROXIDE; PROBES;
D O I
10.3390/antiox13101254
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reactive oxygen species (ROS) are generated during normal cellular energy production and play a critical role in maintaining cellular function. However, excessive ROS can damage cells and tissues, contributing to the development of diseases such as cardiovascular, inflammatory, and neurodegenerative disorders. This review explores the potential of nuclear medicine imaging techniques for detecting ROS and evaluates various radiopharmaceuticals used in these applications. Radiopharmaceuticals, which are drugs labeled with radionuclides, can bind to specific biomarkers, facilitating their identification in vivo using nuclear medicine equipment, i.e., positron emission tomography and single photon emission computed tomography, for diagnostic purposes. This review includes a comprehensive search of PubMed, covering radiopharmaceuticals such as analogs of fluorescent probes and antioxidant vitamin C, and biomarkers targeting mitochondrial complex I or cystine/glutamate transporter.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Nuclear medicine and radiopharmaceuticals
    Novales, P. Sopena
    Plancha Mansanet, M. C.
    Martinez Carsi, C.
    Sopena Monforte, R.
    RADIOLOGIA, 2014, 56 : 29 - 37
  • [2] Technological innovations in nuclear medicine imaging FOREWORD
    Lonsdale, M. N.
    Pedroli, G.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 56 (03): : 219 - 220
  • [3] RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE
    PETERSEN, DA
    LANE, EA
    MORRIS, J
    BOYD, RE
    ATOMIC ENERGY IN AUSTRALIA, 1970, 13 (03): : 2 - &
  • [4] Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals
    Sathekge, Mike
    Maes, Alex
    D'Asseler, Yves
    Vorster, Mariza
    Van de Wiele, Christophe
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (06) : 581 - 590
  • [5] Radiopharmaceuticals and their applications in medicine
    Zhang, Siqi
    Wang, Xingkai
    Gao, Xin
    Chen, Xueyao
    Li, Linger
    Li, Guoqing
    Liu, Can
    Miao, Yuan
    Wang, Rui
    Hu, Kuan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [6] Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine
    Mastascusa, Nic
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2020, 48 (04) : 388 - 389
  • [7] Radiotracers for Nuclear Imaging of Reactive Oxygen Species: Advances Made So Far
    Huang, Lumei
    Li, Zijing
    Zhang, Xianzhong
    BIOCONJUGATE CHEMISTRY, 2022, 33 (05) : 749 - 766
  • [8] Reviews in: Radiopharmaceuticals in nuclear medicine
    Lau, Chuen-Yen
    Mostafa, Mostafa Yuness Abdelfatah
    FRONTIERS IN MEDICINE, 2023, 10
  • [9] Peptide radiopharmaceuticals in nuclear medicine
    D. Blok
    R. I. J. Feitsma
    P. Vermeij
    E. J. K. Pauwels
    European Journal of Nuclear Medicine, 1999, 26 : 1511 - 1519
  • [10] Peptide radiopharmaceuticals in nuclear medicine
    Blok, D
    Feitsma, RIJ
    Vermeij, P
    Pauwels, EJK
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (11) : 1511 - 1519